HARVARD BIOSCIENCE INC's ticker is HBIO and the CUSIP is 416906105. A total of 73 filers reported holding HARVARD BIOSCIENCE INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $853,120 | -21.7% | 198,400 | 0.0% | 0.02% | -19.2% |
Q2 2023 | $1,089,216 | +30.7% | 198,400 | 0.0% | 0.03% | +18.2% |
Q1 2023 | $833,280 | +34.7% | 198,400 | -11.2% | 0.02% | +37.5% |
Q4 2022 | $618,818 | -11.5% | 223,400 | -18.2% | 0.02% | -15.8% |
Q3 2022 | $699,000 | -31.5% | 273,000 | -3.7% | 0.02% | -17.4% |
Q2 2022 | $1,021,000 | -27.1% | 283,600 | +25.8% | 0.02% | -14.8% |
Q1 2022 | $1,400,000 | -50.2% | 225,517 | -43.5% | 0.03% | -48.1% |
Q4 2021 | $2,814,000 | -6.0% | 399,117 | -7.0% | 0.05% | -8.8% |
Q3 2021 | $2,995,000 | -16.2% | 429,117 | 0.0% | 0.06% | -10.9% |
Q2 2021 | $3,575,000 | +92.6% | 429,117 | +26.2% | 0.06% | +82.9% |
Q1 2021 | $1,856,000 | +6.2% | 339,917 | -16.6% | 0.04% | -5.4% |
Q4 2020 | $1,748,000 | +4.6% | 407,517 | -26.6% | 0.04% | -2.6% |
Q3 2020 | $1,671,000 | -14.4% | 555,017 | -11.9% | 0.04% | -2.6% |
Q2 2020 | $1,953,000 | +41.1% | 630,017 | +0.6% | 0.04% | +21.9% |
Q1 2020 | $1,384,000 | -29.7% | 626,217 | -3.0% | 0.03% | +23.1% |
Q4 2019 | $1,969,000 | -0.8% | 645,617 | 0.0% | 0.03% | -3.7% |
Q3 2019 | $1,985,000 | +83.3% | 645,617 | +19.3% | 0.03% | +92.9% |
Q2 2019 | $1,083,000 | -58.4% | 541,317 | -10.5% | 0.01% | -56.2% |
Q1 2019 | $2,605,000 | +28.1% | 604,517 | -5.5% | 0.03% | +18.5% |
Q4 2018 | $2,033,000 | -37.5% | 639,417 | +3.3% | 0.03% | -15.6% |
Q3 2018 | $3,251,000 | -21.1% | 619,217 | -19.6% | 0.03% | -23.8% |
Q2 2018 | $4,119,000 | +7.0% | 769,917 | 0.0% | 0.04% | +2.4% |
Q1 2018 | $3,850,000 | +39.5% | 769,917 | -7.9% | 0.04% | +36.7% |
Q4 2017 | $2,759,000 | -6.3% | 835,917 | +6.4% | 0.03% | -11.8% |
Q3 2017 | $2,946,000 | +63.6% | 785,617 | +11.2% | 0.03% | +54.5% |
Q2 2017 | $1,801,000 | +34.6% | 706,217 | +37.2% | 0.02% | +37.5% |
Q1 2017 | $1,338,000 | +18.8% | 514,717 | +39.5% | 0.02% | +6.7% |
Q4 2016 | $1,126,000 | +63.0% | 369,017 | +45.3% | 0.02% | +50.0% |
Q3 2016 | $691,000 | -3.8% | 254,017 | +1.2% | 0.01% | -9.1% |
Q2 2016 | $718,000 | -5.3% | 251,117 | 0.0% | 0.01% | -15.4% |
Q1 2016 | $758,000 | -13.0% | 251,117 | 0.0% | 0.01% | -18.8% |
Q4 2015 | $871,000 | +14.6% | 251,117 | +24.9% | 0.02% | 0.0% |
Q3 2015 | $760,000 | -33.8% | 201,117 | -0.2% | 0.02% | -30.4% |
Q2 2015 | $1,148,000 | -2.1% | 201,467 | 0.0% | 0.02% | -4.2% |
Q1 2015 | $1,173,000 | +2.9% | 201,467 | +0.2% | 0.02% | -7.7% |
Q4 2014 | $1,140,000 | +38.5% | 201,117 | 0.0% | 0.03% | +23.8% |
Q3 2014 | $823,000 | -10.1% | 201,117 | 0.0% | 0.02% | -12.5% |
Q2 2014 | $915,000 | -4.0% | 201,117 | 0.0% | 0.02% | -11.1% |
Q1 2014 | $953,000 | +0.8% | 201,117 | 0.0% | 0.03% | -6.9% |
Q4 2013 | $945,000 | -10.7% | 201,117 | 0.0% | 0.03% | -19.4% |
Q3 2013 | $1,058,000 | +12.7% | 201,117 | +0.7% | 0.04% | -5.3% |
Q2 2013 | $939,000 | – | 199,817 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Harvey Partners, LLC | 790,000 | $2,378,000 | 3.09% |
Alambic Investment Management, L.P. | 25,398 | $76,000 | 0.83% |
Adirondack Research & Management Inc. | 190,494 | $573,000 | 0.80% |
Archon Capital Management LLC | 881,794 | $2,654,000 | 0.53% |
BARD ASSOCIATES INC | 1,483,610 | $4,465,000 | 0.47% |
DALTON GREINER HARTMAN MAHER & CO | 909,977 | $2,739,000 | 0.45% |
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 1,537,800 | $4,629,000 | 0.40% |
Portolan Capital Management | 979,067 | $2,947,000 | 0.33% |
HEARTLAND ADVISORS INC | 961,400 | $2,894,000 | 0.25% |
Granahan Investment Management | 1,757,176 | $5,289,000 | 0.18% |